Last reviewed · How we verify
NCT03888599
Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination
trial testing knowledge questioannaire in HPV-Related Cervical Carcinoma in 600 participants. Completed in 1 August 2019.
1 June 2019
Quick facts
| Lead sponsor | University Hospital, Geneva |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 600 |
| Start date | 1 April 2019 |
| Primary completion | 1 June 2019 |
| Estimated completion | 1 August 2019 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- knowledge questioannaire
Conditions studied
- HPV-Related Cervical Carcinoma — all drugs for HPV-Related Cervical Carcinoma →
Sponsor
University Hospital, Geneva
Who can join
Adults 18 to 36, any sex, with HPV-Related Cervical Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A better understanding of the target audiences about HPV infection and HPV vaccination would surely allow for a better spread of this vaccination in Switzerland. In order to know if the target audiences are properly informed, we have decided to carry out a study evaluating their level of knowledge on a particular audience that are the men and women undergraduate nurse.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Human Papillomavirus Infection and Vaccination: Knowledge, Attitude and Perception among Undergraduate Men and Women Healthcare University Students in Switzerland.
Jeannot E, Viviano M, Follonier MC, Kaech C, et al · · 2019 · cited 12× · PMID 31561629 · DOI 10.3390/vaccines7040130
Verify or expand the search:
- PubMed search for NCT03888599
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for HPV-Related Cervical Carcinoma
Currently open trials in the same condition.
- NCT05973487 — A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metasta · Phase 1 · active not recruiting
- NCT06598176 — Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples · NA · recruiting
- NCT06052033 — Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk · NA · recruiting
- NCT05996783 — Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial · NA · active not recruiting
- NCT06339684 — HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis · active not recruiting
Other University Hospital, Geneva trials
Trials by the same sponsor.
- NCT07506356 — Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors · recruiting
- NCT07267624 — EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study) · NA · not yet recruiting
- NCT06710210 — Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventi · NA · not yet recruiting
- NCT07173348 — Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea · NA · not yet recruiting
- NCT07129655 — Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Ch · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03888599 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Geneva
- Last refreshed: 26 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03888599.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing